Online citations, reference lists, and bibliographies.
← Back to Search

Emerging Methods For Analysis Of The Cancer Methylome.

J. W. Chang, T. Huang, Yi-Ching Wang
Published 2008 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
CpG island hypermethylation plays a key role in the silencing of cancer-related genes. In recent years, some new and effective methods have been developed for high-throughput analysis of DNA methylation, and have provided DNA methylation markers as powerful tools for the development of innovative diagnostic and therapeutic strategies in cancer. In this review, we describe various current and emerging technologies for studying the DNA methylation profile in cancer including: the isoschizomers and gel-based methylation analysis, the microarray-based methylation analysis and the sequencing-based methylation analysis. All of these techniques have advantages and disadvantages, such as sensitivity, specificity, analysis scale and cost. In the coming years, newer platforms of low cost, high-throughput and greater expediency, and speed for cancer methylome analysis will be developed.
This paper references
10.3892/IJO.31.1.181
DNA methylation markers of surfactant proteins in lung cancer.
Z. Lin (2007)
10.1242/dev.001131
Genome-wide analysis of DNA methylation patterns
D. Zilberman (2007)
10.1038/nrg2005
Cancer epigenomics: DNA methylomes and histone-modification maps
M. Esteller (2007)
10.1093/carcin/bgn170
Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
W. Gao (2008)
10.1038/nrc1507
CpG island methylator phenotype in cancer
J. Issa (2004)
10.1101/GR.202801
Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.
R. Gitan (2002)
Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
P. Yan (2003)
10.1038/366362A0
Role for DNA methylation in genomic imprinting
E. Li (1993)
Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells.
H. Shi (2002)
10.1038/ng1598
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells
M. Weber (2005)
10.1002/path.1024
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
M. Esteller (2002)
10.1093/nar/gkl551
MMASS: an optimized array-based method for assessing CpG island methylation
A. Ibrahim (2006)
10.1038/nmeth726
Mapping DNA-protein interactions in large genomes by sequence tag analysis of genomic enrichment
Jonghwan Kim (2005)
10.1038/nature03959
Genome sequencing in microfabricated high-density picolitre reactors
M. Margulies (2005)
10.1006/GYNO.2001.6291
DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.
A. Ahluwalia (2001)
10.1016/J.GDE.2006.10.009
Whole-genome re-sequencing.
D. Bentley (2006)
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
M. Toyota (1999)
DNA methylation errors and cancer.
P. Jones (1996)
10.1016/j.tig.2008.01.006
The methylome: approaches for global DNA methylation profiling.
S. Beck (2008)
10.1158/0008-5472.CAN-06-1888
MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells.
T. Rauch (2006)
10.1038/ng892
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
H. Suzuki (2002)
10.1038/sj.onc.1209331
Genome-wide profiling of promoter methylation in human
I. Hatada (2006)
10.1038/ng0394-236
Purification of CpG islands using a methylated DNA binding column
S. Cross (1994)
10.1158/0008-5472.CAN-07-5913
Genome-wide promoter analysis uncovers portions of the cancer methylome.
M. Hoque (2008)
10.1158/0008-5472.CAN-07-2687
Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells.
F. V. Jacinto (2007)
10.1038/leu.2008.130
Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia
S-Q Kuang (2008)
10.1101/gr.7301508
Comprehensive high-throughput arrays for relative methylation (CHARM).
R. Irizarry (2008)
10.1158/0008-5472.CAN-07-1016
Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.
K. Taylor (2007)
10.1101/GR.5273806
Comparative isoschizomer profiling of cytosine methylation: the HELP assay.
B. Khulan (2006)
10.1073/PNAS.89.5.1827
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.
M. Frommer (1992)
10.1158/0008-5472.CAN-07-6844
MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
N. Yamada (2008)
10.4161/epi.2.3.4805
Identification of DNA Methylation in 3' Genomic Regions that are Associated with Upregulation of Gene Expression in Colorectal Cancer
J. F. Smith (2007)
10.1038/nature06745
Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning
Shawn Cokus (2008)
10.1093/NAR/29.22.4598
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
C. Nguyen (2001)
10.1093/nar/gni072
Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines
C. Mund (2005)
10.1016/j.cell.2007.05.009
High-Resolution Profiling of Histone Methylations in the Human Genome
A. Barski (2007)
10.1038/72785
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
J. Costello (2000)
10.1073/PNAS.0507816102
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.
M. Ehrich (2005)
10.1038/nature07107
Genome-scale DNA methylation maps of pluripotent and differentiated cells
A. Meissner (2008)
10.1093/CARCIN/BGL161
Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets.
J. Ordway (2006)
10.1093/emboj/cdg604
Methyl‐CpG binding proteins identify novel sites of epigenetic inactivation in human cancer
E. Ballestar (2003)
10.1096/fasebj.10.4.8647346
S‐Adenosylmetliionine and methylation
P. Chiang (1996)
10.1038/nature02651
Role of transposable elements in heterochromatin and epigenetic control
Z. Lippman (2004)
10.1101/GR.6883307
Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA.
Y. Korshunova (2008)
10.1038/ng1719
Evidence for an instructive mechanism of de novo methylation in cancer cells
I. Keshet (2006)
10.1016/J.AB.2006.04.048
Microarray-based molecular margin methylation pattern analysis in colorectal carcinoma.
D. Zhang (2006)
10.1124/JPET.104.072488
Epigenomic Changes during Leukemia Cell Differentiation: Analysis of Histone Acetylation and Cytosine Methylation Using CpG Island Microarrays
M. Nouzova (2004)
10.1016/S1046-2023(02)00070-1
Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation.
P. Yan (2002)
10.1016/j.cell.2008.03.029
Highly Integrated Single-Base Resolution Maps of the Epigenome in Arabidopsis
R. Lister (2008)
10.1093/JNCI/DJM069
Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
H. Bjornsson (2007)
10.1101/GR.4410706
High-throughput DNA methylation profiling using universal bead arrays.
M. Bibikova (2006)
10.1093/BIOINFORMATICS/BTH346
Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates
J. Lewin (2004)
10.1101/GR.6417007
High-throughput methylation profiling by MCA coupled to CpG island microarray.
M. Estécio (2007)
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.
J. A. Fahrner (2002)
10.1158/0008-5472.CAN-05-3865
A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop.
P. Jones (2005)
10.1093/HMG/8.3.459
Methylation profiling of CpG islands in human breast cancer cells.
T. Huang (1999)
10.1038/ng1909
DNA methylation profiling of human chromosomes 6, 20 and 22
Florian Eckhardt (2006)
10.1038/nmeth0305-219
Profiling DNA methylation patterns using genomic tiling microarrays
Z. Lippman (2005)
10.1016/S0168-9525(99)01971-X
DNA hypermethylation in tumorigenesis: epigenetics joins genetics.
S. Baylin (2000)
10.1016/S1535-6108(02)00215-5
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.
K. Yamashita (2002)
10.1093/HMG/DDG226
Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
M. Paz (2003)
10.1038/14328
CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer
T. Huang (1999)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar